Skip to main navigation Skip to search Skip to main content

Genistein as a regulator of signaling pathways and microRNAs in different types of cancers

  • Zeeshan Javed
  • , Khushbukhat Khan
  • , Jesús Herrera-Bravo
  • , Sajid Naeem
  • , Muhammad Javed Iqbal
  • , Haleema Sadia
  • , Qamar Raza Qadri
  • , Shahid Raza
  • , Asma Irshad
  • , Ali Akbar
  • , Željko Reiner
  • , Ahmed Al-Harrasi
  • , Ahmed Al-Rawahi
  • , Dinara Satmbekova
  • , Monica Butnariu
  • , Iulia Cristina Bagiu
  • , Radu Vasile Bagiu
  • , Javad Sharifi-Rad
  • Lahore Garrison University
  • National University of Sciences and Technology Pakistan
  • Universidad Santo Tomás, Santiago
  • Universidad de la Frontera
  • Lanzhou University
  • University of Sialkot
  • Balochistan University of Information Technology, Engineering and Management Sciences
  • University of Veterinary and Animal Sciences, Lahore, Pakistan
  • Lahore University of Management Sciences
  • University of Balochistan
  • University of Zagreb
  • University of Nizwa
  • Al Farabi Kazakh National University
  • Banat University of Agricultural Sciences and Veterinary Medicine
  • Victor Babes University of Medicine and Pharmacy
  • Multidisciplinary Research Center on Antimicrobial Resistance
  • Preventive Medicine Study Center
  • Shahid Beheshti University of Medical Sciences

Research output: Contribution to journal › Review article › peer-review

75 Scopus citations

Abstract

Cancers are complex diseases orchestrated by a plethora of extrinsic and intrinsic factors. Research spanning over several decades has provided better understanding of complex molecular interactions responsible for the multifaceted nature of cancer. Recent advances in the field of next generation sequencing and functional genomics have brought us closer towards unravelling the complexities of tumor microenvironment (tumor heterogeneity) and deregulated signaling cascades responsible for proliferation and survival of tumor cells. Phytochemicals have begun to emerge as potent beneficial substances aimed to target deregulated signaling pathways. Isoflavonoid genistein is an essential phytochemical involved in regulation of key biological processes including those in different types of cancer. Emerging preclinical evidence have shown its anti-cancer, anti-inflammatory and anti-oxidant properties. Testing of this substance is in various phases of clinical trials. Comprehensive preclinical and clinical trials data is providing insight on genistein as a modulator of various signaling pathways both at transcription and translation levels. In this review we have explained the mechanistic regulation of several key cellular pathways by genistein. We have also addressed in detail various microRNAs regulated by genistein in different types of cancer. Moreover, application of nano-formulations to increase the efficiency of genistein is also discussed. Understanding the pleiotropic potential of genistein to regulate key cellular pathways and development of efficient drug delivery system will bring us a step towards designing better chemotherapeutics.

Original languageEnglish
Article number388
JournalCancer Cell International
Volume21
Issue number1
DOIs
StatePublished - Dec 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Genistein
  • Nano-formulations
  • Signaling pathways
  • Therapeutics
  • miRNAs

Fingerprint

Dive into the research topics of 'Genistein as a regulator of signaling pathways and microRNAs in different types of cancers'. Together they form a unique fingerprint.

Cite this